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Summary
Objective:  Review  of  the  treatment  of  cervical  paraganglioma.
Material  and  methods:  Review  of  the  literature  based  on  a  Medline  database.
Results:  The  treatment  of  choice  consists  of  a  multidisciplinary  approach  based  on  a  detailed
clinical, laboratory  and  radiological  work-up.  Vascular  reconstruction  may  be  necessary  when
the tumour  invades  the  artery  wall.  The  main  complication  of  surgery  is  damage  to  cranial  nerves
involved  in  speech  and/or  swallowing.  Treatment  of  bilateral  tumours  must  be  conducted  in
two stages.  The  ﬁrst  side  to  be  operated  depends  on  the  sites  and  size  of  the  tumours,  as
the primary  objective  is  to  avoid  bilateral  vagus  nerve  palsy.  Radiotherapy  has  been  used  to
treat paragangliomas  for  several  years  and  achieves  tumour  stabilization  in  the  majority  of
cases. Potential  indications  reported  in  the  literature  are:  inoperable  tumours,  recurrence  after
surgery,  some  bilateral  tumours  and  malignant  tumours.
Conclusion:  Surgery  is  the  standard  treatment  for  cervical  paraganglioma.  Radiotherapy  can  be
proposed  when  surgery  is  contraindicated.
r  Ma
t
t
t
d
l
p
m
b©  2012  Published  by  Elsevie
ntroduction
aragangliomas  are  rare  tumours  arising  at  the  expense  of
ells  derived  from  the  Amine  Precursor  Uptake  Decarbox-
lation  (APUD)  system.  They  represent  0.6%  of  all  head  and
eck  tumours  [1].  These  cells  have  a  common  embryological
rigin  in  the  neural  crest  from  where  they  migrate  beyond
he  sympathetic  chain  to  acquire  glandular  characteristics
escribed  as  paraganglia.  The  most  common  head  and  neck
aragangliomas  are  those  arising  from  the  carotid  body
nd  vagus  nerve  (X)  [1].  Carotid  body  paragangliomas  are
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hree  times  more  common  than  vagal  paragangliomas.  These
umours  are  mostly  benign  (85—95%  of  cases)  [2].  Surgery  is
he  standard  treatment,  but  some  tumours  are  inoperable
ue  to  the  patient’s  general  status,  or  the  tumour  size  or
ocal  extension  [3].  Bilateral  tumours  also  raise  management
roblems  related  to  complications  of  surgery.  Radiotherapy
ay  constitute  an  alternative  treatment  option,  as  it  has
een  shown  to  be  effective  on  this  type  of  tumour  [4].  The
bjective  of  this  study  is  to  review  the  current  management
f  cervical  paraganglioma.urgical management
reoperative  assessment:  progress  in  imaging  has  consid-
rably  improved  the  assessment  of  paragangliomas  [3,5].
.
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Table  1  Paraganglioma  classiﬁcations.
Netterville  classiﬁcation  Vagal  tumours  A:  tumour
conﬁned  to  the
neck
B:  tumour  in  contact
with  the  jugular
foramen
C:  tumour  penetrating  into  or
extending  beyond  the  jugular
foramen  with  or  without
intracranial  extension
Shamblin classiﬁcation  Carotid  bulb
tumours
I: small  tumour
not  involving  the
carotid  artery
II:  tumour  partially
involving  the  internal
carotid  artery  and/or
the  carotid  bulb
III:  tumour  completely
involving  the  internal  carotid
artery  and/or  the  carotid  bulb
IIIA:  no  contact  with  the  skull
base
IIIB: in  contact  with  the  skull
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aDuring  clinical  assessment,  the  cranial  nerves  must  be  care-
fully  evaluated,  as  a  preoperative  deﬁcit  is  observed  in  30%
of  patients  with  vagal  paraganglioma  and  2%  of  patients  with
carotid  body  paraganglioma  [6].
The  objectives  of  preoperative  assessment  are  as  follows
[5,6]:
•  to  evaluate  the  cervical  mass;
•  to  determine  whether  the  lesion  is  solitary  or  multiple;
•  to  determine  the  nature  of  the  tumour;
• to  perform  a  general  assessment  looking  for  multi-
ple  endocrine  neoplasia,  phaeochromocytoma,  excessive
adrenergic  secretion  syndrome;
• to  look  for  an  associated  genetic  syndrome.
Clinical  examination  must  describe  the  cervical  mass:  its
dimensions,  consistency,  and  mobility.  Ipsilateral  and  con-
tralateral  cervical  lymph  node  areas  are  examined  [5].  An
ENT  examination  looks  for  the  presence  of  any  associated
parapharyngeal  mass.  Ultrasound,  the  reference  exami-
nation  for  neck  masses,  demonstrates  a  heterogeneous,
hypoechoic,  hypervascular  mass  and  allows  bilateral  inves-
tigation  of  cervical  spaces.  CT  scan  visualizes  a  clearly
demarcated  mass  with  rapid,  intense  contrast  enhance-
ment,  concomitant  to  that  of  the  carotid  arteries  and
early  venous  drainage  [3].  Carotid  body  paraganglioma  has
a  characteristic  ‘‘lyre’’  appearance,  while  vagal  paragan-
glioma,  generally  situated  more  superiorly,  displaces  the
carotid  anteriorly  and  medially.  CT  angiography  must  now
be  requested.  CT  visualizes  the  anatomical  relations  of  vagal
paragangliomas  with  respect  to  the  skull  base  [7].
MRI  is  the  standard  investigation  for  carotid  body  para-
ganglioma  [3].  On  T1-weighted  sequences,  the  lesion  has
an  isointense  or  low-intensity  signal,  while,  on  T2-weighted
sequences,  it  usually  has  a  high-intensity  signal.  A  pepper
and  salt  appearance  is  frequently  observed  on  T2-weighted
sequences  due  to  the  tumour  blood  supply.  Intense  gadolin-
ium  enhancement  is  observed  that  may  be  more  or  less
homogeneous  in  the  presence  of  zones  of  tumour  necrosis.
MR  angiography  images  must  be  obtained  to  evaluate  vascu-
lar  displacement,  the  tumour  blood  supply  and  anatomical
relations  of  the  lesion  with  artery  walls.  The  indication  for
arteriography  should  be  discussed  with  the  interventional
radiologist,  as  it  is  no  longer  systematically  indicated  and
is  only  useful  for  embolization  and  clamping  tests.  The
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hamblin  (carotid  body  paragangliomas)  and  Neterville-
lasscock  (vagal  paraganglioma)  classiﬁcations  (Table  1)  are
etermined  on  the  basis  of  this  imaging  assessment  [7—9].
Functional  imaging  is  performed  to  detect  multiple
esions.  Octreoscan® (111Indium)  is  the  reference  modality,
ut 18F-Dihydroxyphenylalanine  (18FDOPA)  positron  emission
omography  is  also  very  reliable  [3,8]. Genetic  testing  must
e  performed  in  all  patients  looking  for  an  SDHx  gene  muta-
ion  [9,10]. A  correlation  has  been  established  between
DHB  gene  mutation  and  the  risk  of  malignancy.  The  risk  of
eveloping  multiple  cervical,  as  well  as  thoracic  and  abdom-
nal  lesions  is  also  higher  than  for  sporadic  forms  [9—11].
Finally,  blood  and  urine  metanephrine  assays  and
lood  pressure  assessment  must  be  performed  [10].
atecholamine-secreting  lesions  are  associated  with  a
igher  anaesthetic  risk.
Indications,  surgical  setting  and  embolization:  surgery
or  cervical  paraganglioma  can  be  associated  with  imme-
iate  serious  complications,  particularly  cerebrovascular
omplications  as  well  as  swallowing  difﬁculties  and  delayed
ecovery  of  neurological  sequelae.  These  complications  can
ead  to  situations  with  a  major  impact  on  quality  of  life
nd  must  be  taken  into  account  when  deﬁning  the  indi-
ations  for  surgical  management.  A  complete  assessment
ust  therefore  be  performed,  comprising  a  multidisciplinary
onsultation,  and  the  patient  must  be  clearly  informed.  All
arameters,  general  status,  age,  associated  lesions,  genetic
actors,  solitary/multiple  tumours,  must  be  considered  dur-
ng  a  joint  consultation  between  the  anaesthetist-intensive
are  physician,  head  and  neck  surgeon,  vascular  surgeon,
euroradiologist,  geriatrician,  etc.,  before  deciding  on  the
reatment  modality.  As  the  estimated  mean  growth  of
 paraganglioma  is  about  1.0  mm/year,  watchful  waiting
ust  therefore  be  considered,  especially  for  vagal  paragan-
liomas  and  in  elderly  and  debilitated  patients  [6,7].
Surgery  for  carotid  body  and  vagal  paragangliomas  must
e  performed  under  conditions  allowing  vascular  surgery
rocedures  [5,6]. When  a  paraganglioma  is  discovered
ncidentally  during  exploratory  cervical  dissection,  it  is
referable  to  postpone  the  operation  until  a  complete
ssessment  has  been  performed,  rather  than  continue  the
rocedure  under  suboptimal  conditions.
Preoperative  embolization  may  be  proposed  after  MRI.
t  is  performed  2  or  3  days  before  surgery,  but  its  effects
limitation  of  blood  loss  and  operating  time,  facilitation  of
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issection)  are  not  unanimously  recognized  [5].  The  risks
f  migration  of  the  embolization  product  are  not  negligible
5—8%),  especially  in  patients  with  carotid  body  paragan-
liomas,  in  which  part  of  the  blood  supply  is  derived  from
he  carotid  bulb  or  the  internal  carotid  artery  [5].  Emboliza-
ion  is  known  to  be  a  factor  of  increased  risk  of  carotid  artery
eplacement  in  carotid  body  paragangliomas  [5].  Emboliza-
ion  now  tends  to  be  reserved  for  vagal  paragangliomas  and
ery  large  tumours  [5,6].
Carotid  stents  were  initially  used  as  alternatives  to
mbolization  in  order  to  exclude  the  tumour  blood  sup-
ly.  They  are  currently  used  in  carotid  body  paraganglioma
urgery  to  devascularize  the  tumour  without  interrupting
he  arterial  blood  ﬂow  and  to  facilitate  tumour  resection.
he  published  results  concern  limited  series  of  patients  with
dvanced  tumours  or  patients  in  whom  the  carotid  artery
ad  already  been  sacriﬁced  [12].
The  incision  must  be  sufﬁciently  large  to  allow  control  of
eurovascular  structures  and  must  consist  of  at  least  a classi-
al  cervical  incision,  possibly  extended  to  a  cervico-parotid
r  even  a  cervico-parotido-mastoid  incision.  Lymphadenec-
omy  is  not  performed  systematically,  but  only  when  lymph
ode  metastasis  is  demonstrated  [8].
Carotid  body  paragangliomas:  the  ﬁrst  step  consists  of
issection  of  the  common  carotid  and  internal  and  external
arotid  arteries  as  far  as  the  superior  and  inferior  poles  of
he  tumour.  Dissection  is  then  continued  from  the  periphery
o  the  carotid  bulb  after  having  isolated  the  XII,  X,  and  XI
ranial  nerves.  This  carotid  artery  dissection  does  not  always
equire  ligation  of  the  external  carotid  artery  or  its  branches
nd  is  performed  subadventitially  with  careful  control  of
aemostasis.  Finally,  the  carotid  bulb  is  dissected  by  care-
ully  advancing  towards  the  bifurcation,  which  constitutes
he  zone  at  greatest  risk  of  rupture,  as  it  corresponds  to  the
ite  of  the  artery  to  the  bulb  and  the  thinnest  part  of  the
rterial  wall.  Poor  arterial  control  can  lead  to  rupture,  which
s  then  very  difﬁcult  to  control.  When  carotid  artery  replace-
ent  is  necessary,  ligation-section  of  the  carotid  artery  after
eparinization  and  immediate  anastomosis  with  a  clamping
ime  always  less  than  25  minutes  is  performed  with  the  assis-
ance  of  a  vascular  surgeon.  When  more  time  is  required
o  perform  a  complex  anastomosis  (for  example,  via  a  skull
ase  approach),  it  can  be  performed  with  a  temporary  shunt
13—15].
Vagal  paragangliomas:  surgery  for  vagal  paraganglioma
s  conducted  according  to  the  same  principles  as  carotid
ody  paraganglioma  surgery.  The  parapharyngeal  space  is
xposed  by  retraction  of  the  digastric  and  stylohyoid  mus-
les.  Facial  nerve  dissection  is  not  systematic.  Carotid  artery
issection  often  raises  fewer  problems  than  for  carotid
ody  paragangliomas.  Access  to  the  superior  pole  of  the
umour  may  be  difﬁcult  due  to  dissection  of  the  bony  ret-
ostyloid  space.  The  proximity  of  the  skull  base  requires
issection  in  a  conﬁned  zone,  further  increasing  the  difﬁ-
ulties,  especially  when  the  tumour  is  very  large  and  poorly
ompressible.  Tumour  debulking  may  need  to  be  performed
y  intratumoural  resection.  The  difﬁculty  of  dissection  of
he  cranial  nerves  (IX,  X,  XI,  XII)  is  variable,  but  the  nerves
an  be  difﬁcult  to  distinguish  within  the  tumour  capsule.
he  vagus  nerve  can  never  be  preserved  [9].  Two  options
re  available  when  the  tumour  penetrates  into  the  jugular
oramen.  In  the  case  of  limited  extension,  the  sphenoidal
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pine  can  be  exposed  over  several  millimetres  via  an  infe-
ior  approach,  providing  access  to  the  carotid  canal.  In  the
resence  of  more  advanced  extension,  complex  approaches
transmandibular,  transmastoid,  transvertebro-occipital  or
nfratemporal)  may  be  necessary.  Cranial  nerve  preservation
s  unlikely  in  the  presence  of  an  advanced  tumour.
Most  of  the  recently  published  series  report  com-
lete  resection  in  every  case  with  very  low  postoperative
ortality  [8].  A  vascular  procedure  is  necessary  in
ess  than  10%  of  cases.  Cerebrovascular  complications
postoperative  prosthesis  thrombosis  with  transient  cere-
ral  complications,  immediate  postoperative  haemorrhage
equiring  redo  surgery)  are  reported  in  less  than  2%  of  cases
8,13,14].  Vascular  complications  are  correlated  with  the
ize  of  the  tumour  and  carotid  artery  involvement.  The
omplication  rate  is  15%  for  Shamblin  stage  3  tumours  ver-
us  0%  for  Shamblin  stage  1  and  2  tumours  [8].  Immediate
ostoperative  neurological  complications  are  observed  in
2%  of  patients,  but  these  disorders  are  generally  transient
especially  hypoglossal  and  vagal).  Persistent  swallowing  dis-
rders  are  reported  by  3.5%  of  patients  (tumours  >  4  cm).
lobally,  major  complications  (permanent  nerve  palsy,  swal-
owing  disorders,  intraoperative  and  postoperative  vascular
omplications)  are  reported  in  14%  of  cases  (Shamblin  1-
:  2.3%  but  Shamblin  grade  3  and  tumour  diameter  >  4  cm:
5.7%)  [8,13].
The  functional  complications  of  vagal  paraganglioma
epend  on  tumour  size:  tumours  less  than  2  cm  in  diame-
er  can  generally  be  removed  with  functional  impairment
imited  to  the  vagus  nerve.  Multiple  nerve  lesions  make  post-
perative  rehabilitation  much  more  difﬁcult  [7,8,13,14].
ecovery  of  speech  and  swallowing  functions  can  be  very
ong.  Variable  deﬁcits  of  soft  palate  occlusion  and  pharyn-
eal  and  laryngeal  dynamics  require  speech  therapy  [6,7].
edo  surgery  to  protect  the  airways  may  be  necessary  in
atients  with  very  severe  swallowing  disorders:  thyroplasty,
ocal  cord  injection,  gastrostomy  or  even  tracheotomy  and
irway  protection  [7—9,15].  Immediate  postoperative  swal-
owing  disorders  are  reported  in  as  many  as  60  to  80%  of
ases,  and  are  persistent  (multiple  paralysis  of  X,  XII,  IX,
nd  superior  laryngeal  nerve)  in  50%  of  cases,  requiring  feed-
ng  gastrostomy.  Respiratory  complications,  including  severe
spiration  pneumonia,  have  also  been  reported  [8,9].
Malignancy  is  conﬁrmed  by  the  presence  of  lymph  node
r  visceral  metastases.  Less  than  5%  of  carotid  body  para-
angliomas  give  rise  to  metastases,  while  metastatic  forms
f  vagal  paraganglioma  are  more  common  [16].
Bilateral  forms,  either  synchronous  or  metachronous,  are
bserved  in  4  to  20%  of  patients  [15,16]. Bilateral  forms  may
e  either  familial  or  sporadic.  Familial  forms  are  the  most
ommon  and  correspond  to  cases  with  an  SDHB, SDHC  or
DHD  (succinate  dehydrogenase)  gene  mutation  with  autoso-
al  dominant  transmission  and  variable  penetrance  [9,11].
arotid  bulb  paraganglioma  is  the  most  common  familial
orm,  representing  10  to  50%  of  all  bilateral  cervical  para-
angliomas  (Fig.  1)  [8].
Surgery  for  bilateral  paragangliomas  must  take  into
ccount: the  patient’s  age,  general  state  of  health  and  comorbid-
ity;
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Figure  1  Bilateral  carotid  bulb  paraganglioma  in  a  21-year-old  woman.  A.  Postcontrast  computed  tomography  (CT)  of  the  neck,
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aaxial scan.  B.  Postcontrast  CT  with  3D  reconstruction.  C. 111Ind
•  tumour  sites;
•  the  size  of  each  tumour.  There  is  a  consensus  to  treat
bilateral  tumours  sequentially  due  to  the  risk  of  nerve
lesions  related  to  surgery  [9].
The  choice  of  the  ﬁrst  side  to  be  operated  is  based  on
the  site  and  size  of  the  tumours.  In  the  case  of  a  carotid
bulb  tumour  on  one  side  and  a  vagal  tumour  on  the  other
side,  the  carotid  bulb  tumour  should  be  operated  ﬁrst  to
limit  the  risk  of  bilateral  vagus  nerve  palsy  [8,9]. In  the
case  of  bilateral  vagal  paragangliomas,  bilateral  laryngeal
nerve  palsy  causes  swallowing,  speech  and/or  breathing  dis-
orders,  clearly  emphasizing  the  need  for  cranial  nerve  (IX,
X,  XII)  examination  before  treating  the  contralateral  side,  as
indicated  by  Netterville  in  1995  [9].  Other  rarer  and  lesser-
known  consequences  related  to  bilateral  vagus  nerve  palsy
have  been  reported:  cardiac  arrhythmias  (sinus  tachycardia)
and/or  positional  blood  pressure  instability  with  disabling
orthostatic  hypotension  [17]. These  blood  pressure  abnor-
malities  differ  from  the  uncontrolled  hypertension  reported
in  several  cases  of  bilateral  carotid  bulb  dissection  due  to
damage  to  carotid  baroreceptors  [8,18].
The  other  parameter  to  be  taken  into  account  is  tumour
size.  Several  studies  have  demonstrated  that  cranial  nerve
lesions  and  sacriﬁce  of  the  carotid  artery  are  statistically
n
a
n
tcintigraphy  (Octreoscan®).
orrelated  with  tumour  size  [8,15,18,19]. Consequently,  the
rst  side  to  be  operated  must  therefore  be  the  side  with  the
maller  tumour  [15,19].
Another  problem  raised  by  the  treatment  of  bilateral  cer-
ical  paragangliomas  is  what  to  do  when  one  side  has  already
een  operated,  resulting  in  severe  and  permanent  swallow-
ng  sequelae  and/or  postoperative  vascular  complications?
ne  option  consists  of  clinical  and  radiological  surveillance,
hich  can  be  justiﬁed  by  the  fact  that  tumour  growth  is
ery  slow,  as  Jansen  et  al.  estimated  that  the  tumour  dou-
ling  time  was  4.2  years,  with  an  estimated  mortality  of
ontreated  paragangliomas  in  patients  over  the  age  of  70
f  less  than  10%  per  year  [20]. It  therefore  appears  reason-
ble  to  simply  watch  small  tumours  in  elderly  patients.  The
econd  argument  in  favour  of  watchful  waiting  is  that  these
umours  are  only  exceptionally  malignant  [20,21]. However,
o  preoperative  criteria  predictive  of  malignancy  have  been
dentiﬁed.  Vagal  paragangliomas  and  dopamine-secreting
umours  are  more  frequently  malignant  [22]. The  frequency
f  malignant  forms  at  the  time  of  diagnosis  is  difﬁcult  to
ssess,  as  the  only  unanimously  recognised  criteria  of  malig-
ancy  are  the  presence  of  cervical  lymph  node  metastases
nd/or  distant  metastases  [23]. The  benign  or  malignant
ature  of  the  tumour  is  therefore  a  poorly  discriminant  cri-
erion  for  the  management  of  bilateral  paraganglioma.  The
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Bilateral cervical paraganglioma
Bilateral carod body paraganglioma Carod paraganglioma and vagal
paraganglioma
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dFigure  2  Flow-diagram  of  the  manag
ther  treatment  option  can  consist  of  radiotherapy  to  the
ther  side.  Fig.  2  summarizes  the  proposed  management  for
ilateral  cervical  paraganglioma.
adiotherapy
o  consensus  has  been  reached  concerning  the  indi-
ations  for  radiotherapy  in  cervical  paraganglioma,
hich  essentially  correspond  to  surgical  contraindica-
ions.
Despite  considerable  follow-up  with  the  use  of  radio-
herapy  for  the  treatment  of  paragangliomas  in  general,
 review  of  the  literature  does  not  allow  clear  guide-
ines  [4,24,25].  Most  series  are  mixed,  composed  of  various
ites  of  paragangliomas  (tympanojugular,  carotid  bulb,  vagus
erve),  making  it  difﬁcult  to  analyse  the  results  for  each  sub-
ite  [26]. Tympanojugular  sites  are  most  commonly  treated
y  radiotherapy,  but  few  studies  have  been  published  on
he  treatment  of  carotid  bulb  and  vagal  paragangliomas
4,27—30].
Regardless  of  the  site  of  the  paraganglioma,  there
s  a  consensus  to  irradiate  advanced  tumours  in  elderly
atients  and/or  patients  with  severe  comorbidity,  unre-
ectable  tumours,  recurring  after  surgery,  or  postoperatively
alignant  forms.  Radiotherapy  to  residual  tumour  is  more
ontroversial  [31,32].  It  is  designed  to  control  tumour
rowth  by  ensuring  clinical  and  radiological  stabilization
<  20%  of  cases)  [32]. The  long-term  risk  of  second  cancer
<  1/1000)  must  also  be  taken  into  account  and  this  tech-
ique  is  therefore  generally  reserved  for  elderly  patients
33].The  indication  for  irradiation  of  large  paragangliomas
ust  be  weighed  up  against  the  surgical  risks  [34]. For
xample,  some  authors  propose  radiotherapy  when  carotid
rtery  resection  is  required,  based  on  the  site  and  size
t
C
t
wnt  of  bilateral  cervical  paraganglioma.
f  the  paraganglioma  [25]. Radiotherapy  is  also  proposed
hen  one  or  several  cranial  nerve  palsies  are  likely,  inducing
ajor  swallowing  and/or  breathing  and/or  speech  disorders
25—35].
Radiotherapy  may  also  be  indicated  in  bilateral  forms
n  the  presence  of  complications  and  sequelae  following
urgery  on  the  ﬁrst  side  and  when  bilateral  nerve  lesions
re  likely  to  compromise  quality  of  life  [36,37].  The  neuro-
ogical  complication  rate  related  to  radiotherapy  is  9.5%  in
his  setting  [38].
In the  studies  by  Hinerman  and  Chino,  with  a  mean
ollow-up  of  10  years,  the  local  control  rate  for  paragan-
liomas  was  95%  for  all  sites  and  96%  for  carotid  bulb  tumours
25—39].  However,  some  studies  comparing  radiotherapy
ersus  surgery  have  reported  very  good  control  rates.  Radio-
herapy  is  associated  with  decreased  morbidity,  regardless
f  the  site  [32].
Conventional  2D  irradiation  is  responsible  for  more
evere  sequelae,  even  despite  classical  fractionation  of  45  to
0  Gy  in  25  fractions  of  2  Gy.  More  recent  modalities  of  radio-
herapy  now  allow  decreased  irradiation  of  healthy  tissues
djacent  to  the  tumour,  such  as  conformal  radiotherapy,  3D
onformal  intensity-modulated  radiotherapy  and  stereotac-
ic  radiosurgery  (Fig.  3).  Gammaknife  was  the  stereotactic
odality  most  commonly  used  as  a  single  fraction,  while
onventional  stereotactic  radiosurgery  is  based  on  frac-
ionation  in  25  to  30  sessions  of  1.8—2  Gy  [27—29]. The
yberknife  is  a  new  modality  of  whole-body  stereotactic
adiotherapy,  allowing  the  treatment  of  extracranial  sites,
ven  mobile  lesions,  by  hypofractionation  (1  to  3  sessions
or  paragangliomas).  Stereotactic  radiosurgery  allows  high
ose  gradients  and  therefore  high  tumour  doses  and  limited
oxicity  to  healthy  tissues.  In  a  preliminary  study  using  the
yberKnife  with  either  a  single  fraction  or  three  fractions,
he  local  control  rate  was  100%  and  the  complication  rate
as  0%  [40].
Treatment  of  cervical  paragangliomas  
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[Figure  3  3D  conformal  radiotherapy,  3D  conformal  intensity-
modulated  radiotherapy  for  paraganglioma.
Conclusion
Surgery  is  the  standard  treatment  for  cervical  paragan-
gliomas,  but  surgical  complications,  particularly  neurolog-
ical  complications,  can  be  considerable.  Radiotherapy  is  an
alternative  when  surgery  is  contraindicated  and  in  selected
cases,  especially  bilateral  and/or  unresectable  tumours.
However,  the  objective  of  radiotherapy  is  not  complete
eradication  of  the  tumour,  but  rather  stabilization  or  partial
tumour  regression.
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